芪参益气滴丸治疗气虚血瘀型冠心病的研究进展  

THE PROGRESS ON QISHENYIQI DROP PILLS TREATING IN BLOOD CORDNARY ATHEROSCLEROTIC HEART DISEASE

作　　者：高扬[1] 刘春甫[2] 

机构地区：[1]内蒙古医学院,内蒙古呼和浩特010059 [2]内蒙古自治区中蒙医院

出　　处：《内蒙古医科大学学报》2010年第S3期46-49,共4页Journal of Inner Mongolia Medical University

摘　　要：芪参益气滴丸是由天津天士力制药股份有限公司研发的一种中成制药,通过多年的临床研究,芪参益气滴丸的临床应用越来越广泛,作用机理也不断明确,现将其治疗气虚血瘀型冠心病的研究进展进行综述,为该药今后在心血管领域中的进一步研究提供参考。The Chinese medicine called Qishenyiqi drop pills is made by tianshili company of Tianjin.According clinical research for years,the clinical use of Qishenyiqi drop pills is more and more widespread and its effect mechanism is becoming clear and definite.Summarise the research progress of Qishenyiqi drop pills treating coronary atherosclerotic heart disease(CHD) in order to provide a reference for its future research in the field of circulate system.

关 键 词：芪参益气滴丸 冠心病 研究进展 

分 类 号：R259[医药卫生—中西医结合]